Last reviewed · How we verify
EffCaMgCit
EffCaMgCit is a combination supplement that provides bioavailable forms of calcium, magnesium, and citrate to support mineral homeostasis and bone health.
EffCaMgCit is a combination supplement that provides bioavailable forms of calcium, magnesium, and citrate to support mineral homeostasis and bone health. Used for Calcium and magnesium supplementation for bone health and mineral deficiency prevention.
At a glance
| Generic name | EffCaMgCit |
|---|---|
| Also known as | Effervescent calcium magnesium citrate |
| Sponsor | University of Texas Southwestern Medical Center |
| Drug class | Mineral supplement / Nutritional formulation |
| Modality | Small molecule |
| Therapeutic area | Bone Health / Metabolic Health |
| Phase | Phase 3 |
Mechanism of action
The drug combines effervescent calcium citrate with magnesium and additional citrate to enhance absorption and utilization of these essential minerals. Citrate acts as a carrier to improve bioavailability of calcium and magnesium while also providing alkalinizing effects. This formulation is designed to support bone mineralization, muscle function, and metabolic health.
Approved indications
- Calcium and magnesium supplementation for bone health and mineral deficiency prevention
Common side effects
- Gastrointestinal upset
- Constipation
- Nausea
Key clinical trials
- EffCaMgCit to Prevent Mineral Metabolism and Renal Complications of Chronic PPI Therapy (PHASE3)
- Potential Therapeutic Role of Effervescent Calcium-Magnesium Citrate in Chronic Kidney Disease Stage V (PHASE2, PHASE3)
- Averting Complications of Proton Pump Inhibitor Therapy by Effervescent Calcium Magnesium Citrate (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- EffCaMgCit CI brief — competitive landscape report
- EffCaMgCit updates RSS · CI watch RSS
- University of Texas Southwestern Medical Center portfolio CI